Huskins Priya Cherian 4
4 · Envoy Medical, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Huskins Priya Cherian
Director
Transactions
- Conversion
Class B Common Stock, par value $0.0001 per share
2023-09-29−25,000→ 0 total→ Class A Common Stock, par value $0.0001 per share (25,000 underlying) - Conversion
Class A Common Stock, par value $0.0001 per share
2023-09-29+25,000→ 25,000 total
Footnotes (1)
- [F1]On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Huskins resigned as a director of Anzu.